cyclopentane has been researched along with Hypertrophy, Left Ventricular in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, IM; Li, J; Littlejohn, R; Liu, J; Ma, W; Stansfield, BK; Su, H; Weintraub, NL; Zhou, J; Zou, J | 1 |
Chagas, C; Groban, L; Jessup, JA; Lin, MS; Lindsey, SH; Wang, H | 1 |
2 other study(ies) available for cyclopentane and Hypertrophy, Left Ventricular
Article | Year |
---|---|
Transient inhibition of neddylation at neonatal stage evokes reversible cardiomyopathy and predisposes the heart to isoproterenol-induced heart failure.
Topics: Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Cyclopentanes; Disease Models, Animal; Heart Failure; Hypertrophy, Left Ventricular; Isoproterenol; Myocytes, Cardiac; NEDD8 Protein; Pyrimidines; Rats, Sprague-Dawley; Ubiquitin-Conjugating Enzymes; Ubiquitination; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Activation of GPR30 attenuates diastolic dysfunction and left ventricle remodelling in oophorectomized mRen2.Lewis rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium; Cardiotonic Agents; Cell Line; Collagen; Cyclopentanes; Echocardiography, Doppler; Estrogens; Female; Gene Expression Regulation; Genotype; Hypertrophy, Left Ventricular; Injections, Subcutaneous; Mice; Myocytes, Cardiac; NADPH Oxidase 4; NADPH Oxidases; Natriuretic Peptide, Brain; Ovariectomy; Phenotype; Quinolines; Rats; Rats, Inbred Lew; Rats, Transgenic; Receptors, G-Protein-Coupled; Renin; RNA, Messenger; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2012 |